Viome, a company transforming health through personalized nutrition based on individual biology, announced it will collaborate with precision health leader, Helomics, to study the link between the gut microbiome and ovarian cancer. The teams will […]
It may be possible to lower the high risk of preterm birth among African American women with certain immune and bacterial factors in the microbiome of the cervix and vagina that appear to modulate this […]
Results from a clinical trial performed by Taverniti and colleagues from the University of Milan (IT) suggest that ingesting higher doses of multispecies probiotic formulations may permit higher, earlier and longer recovery of probiotics in […]
While the microbiome space is often compared to the traditional pharmaceutical and biotechnology industries, the scientific, regulatory, and marketing strategies for microbiome products and platforms often differ from those centered on a single small molecule or large […]
The Microbiome Therapeutics Innovation Group (MTIG) announced the publication of its Position Statement on Fecal Microbiota Transplantation (FMT) treatment. The statement supports the FDA Draft Guidance providing for patient access to FMT treatment through clinical […]
ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics, has entered into a research and […]
Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced a three-year research collaboration with AstraZeneca. The collaboration will focus on advancing mechanistic understanding of the microbiome in augmenting the efficacy of cancer immunotherapy, including potential synergy with […]
SNIPR BIOME, a leading CRISPR and microbiome private biotech company incorporated in Copenhagen, Denmark, today announced a $50 million series A financing led by existing investor Lundbeckfonden Emerge (Copenhagen) and LSP (Amsterdam), together with North-East […]
L’Oréal announced a partnership between its Technology Incubator and Silicon Valley-based uBiome, the leader in microbial genomics, to continue its longtime research into skin microbiome—the trillions of bacteria that live on, and provide an important […]
In your life as a Regulatory Affairs professional, it will invariably dawn on you at some point that concepts which are at the heart of your daily responsibilities (and which eventually begin to seem obvious, […]
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, announces it has completed the first closing of its second dedicated fund focused on the microbiome, and health, […]